A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN

NCT ID: NCT04032093

Last Updated: 2022-10-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

1153 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-07

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This Phase 2b study will evaluate the safety, tolerability, and immunogenicity of an RSV vaccine in pregnant participants who receive either one of 2 dose levels of the vaccine, formulated with or without aluminum hydroxide, or placebo, and investigate safety and characteristics of antibodies in their infants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This Phase 2b, multicenter, randomized, placebo-controlled study will evaluate the safety, tolerability, and immunogenicity of a respiratory syncytial virus stabilized prefusion F subunit vaccine (RSV vaccine) in pregnant participants who receive either one of 2 dose levels of the vaccine, formulated with or without aluminum hydroxide, or placebo, as well as assess safety and characteristics of transplacentally transferred antibodies in their infants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Tract Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
This is an observer-blinded study. Study staff dispensing and administering the vaccine will be unblinded, but the participant and all other study personnel, including the principal investigator, will be blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RSV dose with aluminum hydroxide

RSV vaccine with aluminum hydroxide

Group Type EXPERIMENTAL

RSV vaccine

Intervention Type BIOLOGICAL

RSV vaccine

RSV dose without aluminum hydroxide

RSV vaccine without aluminum hydroxide

Group Type EXPERIMENTAL

RSV vaccine

Intervention Type BIOLOGICAL

RSV vaccine

Higher RSV dose with aluminum hydroxide

Higher dose level RSV vaccine with aluminum hydroxide

Group Type EXPERIMENTAL

RSV vaccine

Intervention Type BIOLOGICAL

RSV vaccine

Higher RSV dose without aluminum hydroxide

Higher dose level RSV vaccine without aluminum hydroxide

Group Type EXPERIMENTAL

RSV vaccine

Intervention Type BIOLOGICAL

RSV vaccine

Placebo dose

Normal saline solution for injection (0.9% sodium chloride injection)

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type BIOLOGICAL

Normal saline solution for injection (0.9% sodium chloride injection)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RSV vaccine

RSV vaccine

Intervention Type BIOLOGICAL

Placebo

Normal saline solution for injection (0.9% sodium chloride injection)

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy women 18 to 49 years of age between 24 and 36 weeks of gestation on the day of planned vaccination, with an uncomplicated pregnancy, who are at no known increased risk for complications, and whose fetus has no significant abnormalities observed on ultrasound.
* Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.
* Receiving prenatal standard of care.
* Had an ultrasound performed at \>=18 weeks of pregnancy.
* Had a negative urinalysis for protein and glucose at the screening visit. Trace protein in the urine is acceptable if the blood pressure is also normal.
* Determined by medical history, physical examination, screening laboratory assessment, and clinical judgment to be appropriate for inclusion in the study.
* Documented negative human immunodeficiency virus antibody, hepatitis B virus surface antigen, hepatitis C virus antibody, and syphilis tests at the screening visit.
* Body mass index of \</=40 kg/m2 at the time of the screening visit.
* Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the informed consent document and in this protocol.
* Expected to be available for the duration of the study and willing to give informed consent for her infant to participate in the study.


* Evidence of a signed and dated ICD signed by the parent(s).
* Parent(s) willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.

Exclusion Criteria

* Bleeding diathesis or condition associated with prolonged bleeding that would, in the opinion of the investigator, contraindicate intramuscular injection.
* History of severe adverse reaction associated with a vaccine and/or severe allergic reaction to any component of the investigational product or any related vaccine.
* History of latex allergy.
* History of any severe allergic reaction.
* Participants with known or suspected immunodeficiency.
* Current pregnancy resulting from in vitro fertilization or other assisted reproductive technology.
* A prior history of or known current pregnancy complications or abnormalities that will increase the risk associated with the participant's participation in and completion of the study.
* Major illness of the mother or conditions of the fetus that, in the investigator's judgment, will substantially increase the risk associated with the participant's participation in, and completion of, the study or could preclude the evaluation of the participant's response.
* Participant with a history of autoimmune disease or an active autoimmune disease requiring therapeutic intervention including but not limited to systemic or cutaneous lupus erythematosus, autoimmune arthritis/rheumatoid arthritis, Guillain-Barré syndrome, multiple sclerosis, Sjögren's syndrome, idiopathic thrombocytopenia purpura, glomerulonephritis, autoimmune thyroiditis, giant cell arteritis (temporal arteritis), psoriasis, and insulin-dependent diabetes mellitus (type 1).
* Other acute or chronic medical or psychiatric condition including recent (within the past year) or active suicidal ideation or behavior or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the participant inappropriate for entry into this study.
* Participation in other studies involving investigational drug(s) within 28 days prior to study entry and/or during study participation.
* Participants who receive treatment with immunosuppressive therapy including cytotoxic agents or systemic corticosteroids (such as for cancer or an autoimmune disease), or planned receipt of such treatment or agents during study participation. If systemic corticosteroids have been administered short term (\<14 days) for treatment of an acute illness, participants should not be enrolled into the study until corticosteroid therapy has been discontinued for at least 30 days before investigational product administration. Inhaled/nebulized, intra articular, intrabursal, or topical (skin or eyes) corticosteroids are permitted.
* Current alcohol abuse or illicit drug use.
* Receipt of blood or plasma products or immunoglobulin, from 60 days before investigational product administration, or planned receipt through delivery, with 1 exception, Rho(D) immune globulin (eg, RhoGAM), which can be given at any time.
* Previous vaccination with any licensed or investigational RSV vaccine or planned receipt during study participation.
* Laboratory test results at the screening visit outside the normal reference value for pregnant women according to their trimester in pregnancy.
* Participants who are breastfeeding at the time of the screening visit.


• Infant who is a direct descendant (eg, child or grandchild) of the study personnel.
Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's of Alabama

Birmingham, Alabama, United States

Site Status

UAB Women & Infants Center - UAB Medicine

Birmingham, Alabama, United States

Site Status

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

Cullman Clinical Research, Inc

Cullman, Alabama, United States

Site Status

Cullman Primary Care, PC

Cullman, Alabama, United States

Site Status

Cullman Regional

Cullman, Alabama, United States

Site Status

Arrowhead Hospital

Glendale, Arizona, United States

Site Status

Abrazo West Campus Hospital

Goodyear, Arizona, United States

Site Status

St. Joseph Hospital

Phoenix, Arizona, United States

Site Status

MedPharmics, LLC

Phoenix, Arizona, United States

Site Status

Mesquite Pediatrics

Tucson, Arizona, United States

Site Status

Watching Over Mothers and Babies

Tucson, Arizona, United States

Site Status

Join Clinical Trials

Bellflower, California, United States

Site Status

Chowchilla Hospital Clinic

Chowchilla, California, United States

Site Status

Join Clinical Trials

Huntington Park, California, United States

Site Status

Matrix Clinical Research

Huntington Park, California, United States

Site Status

Join Clinical Trials

Los Angeles, California, United States

Site Status

East Los Angeles Doctors Hospital

Los Angeles, California, United States

Site Status

White Memorial Medical Center

Los Angeles, California, United States

Site Status

Join Clinical Trials

Los Angeles, California, United States

Site Status

Matrix Clinical Research

Los Angeles, California, United States

Site Status

Affiliated Physician Practice

Madera, California, United States

Site Status

Charles E. Ugwu-Oju, MD, FACOG

Madera, California, United States

Site Status

Madera Community Hospital

Madera, California, United States

Site Status

Madera Family Medical Group

Madera, California, United States

Site Status

Monterey Park Hospital

Monterey Park, California, United States

Site Status

Children's Hospital Colorado

Aurora, Colorado, United States

Site Status

University of Colorado Anschutz Inpatient Pavilion 2

Aurora, Colorado, United States

Site Status

University of Colorado AO1

Aurora, Colorado, United States

Site Status

University of Colorado Hospital Inpatient Pavilion

Aurora, Colorado, United States

Site Status

University of Colorado Hospital Outpatient Pavilion

Aurora, Colorado, United States

Site Status

University of Colorado Leprino Building

Aurora, Colorado, United States

Site Status

University of Colorado Research II Building

Aurora, Colorado, United States

Site Status

Emory Children's Center

Atlanta, Georgia, United States

Site Status

Bingham Memorial Hospital

Blackfoot, Idaho, United States

Site Status

Elite Clinical Trials LLLP

Blackfoot, Idaho, United States

Site Status

Grove Creek Medical Center

Blackfoot, Idaho, United States

Site Status

Clinical Research Prime

Idaho Falls, Idaho, United States

Site Status

Eastern Idaho Regional Medical Center

Idaho Falls, Idaho, United States

Site Status

Family First Medical Center

Idaho Falls, Idaho, United States

Site Status

Mountain View Hospital

Idaho Falls, Idaho, United States

Site Status

Snake River Research, PLLC

Idaho Falls, Idaho, United States

Site Status

The Pediatric Center

Idaho Falls, Idaho, United States

Site Status

Saltzer Medical Group

Nampa, Idaho, United States

Site Status

ASR, LLC

Nampa, Idaho, United States

Site Status

Saltzer Medical Group

Nampa, Idaho, United States

Site Status

Pocatello Women's Health Clinic

Pocatello, Idaho, United States

Site Status

Portneuf Medical Center

Pocatello, Idaho, United States

Site Status

The Pediatric Center

Rigby, Idaho, United States

Site Status

The Iowa Clinic

Ankeny, Iowa, United States

Site Status

Methodist West Hospital

West Des Moines, Iowa, United States

Site Status

The Iowa Clinic

West Des Moines, Iowa, United States

Site Status

Alliance for Multispecialty Research, LLC

El Dorado, Kansas, United States

Site Status

Hutchinson Clinic, P.A.

Hutchinson, Kansas, United States

Site Status

Hutchinson Regional Medical Center

Hutchinson, Kansas, United States

Site Status

Cambridge Medical Trials

Alexandria, Louisiana, United States

Site Status

MedPharmics, LLC

Metairie, Louisiana, United States

Site Status

Allina Health Blaine Clinic

Blaine, Minnesota, United States

Site Status

Allina Health Coon Rapids Clinic

Coon Rapids, Minnesota, United States

Site Status

Allina Health Mercy Women's Clinic

Coon Rapids, Minnesota, United States

Site Status

Mercy Hospital (Allina Health)

Coon Rapids, Minnesota, United States

Site Status

The Mother Baby Center at Mercy with Children's (Allina Health)

Coon Rapids, Minnesota, United States

Site Status

Allina Health Fridley Clinic

Fridley, Minnesota, United States

Site Status

Infectious Disease Research

Minneapolis, Minnesota, United States

Site Status

Abbott Northwestern Hospital (Allina Health)

Minneapolis, Minnesota, United States

Site Status

Oshsner Medical Center - Hancock

Bay Saint Louis, Mississippi, United States

Site Status

Merit Health Biloxi

Biloxi, Mississippi, United States

Site Status

Gulfport Memorial Hospital

Gulfport, Mississippi, United States

Site Status

Gulfport OB-GYN

Gulfport, Mississippi, United States

Site Status

MedPharmics, LLC

Gulfport, Mississippi, United States

Site Status

Singing River Health System

Gulfport, Mississippi, United States

Site Status

St Lukes Hospital

Chesterfield, Missouri, United States

Site Status

Baer Pediatrics

St Louis, Missouri, United States

Site Status

KDB Enterprises

St Louis, Missouri, United States

Site Status

Mercy Hospital St. Louis

St Louis, Missouri, United States

Site Status

Sundance Clinical Research, LLC

St Louis, Missouri, United States

Site Status

Boeson Research

Great Falls, Montana, United States

Site Status

Boeson Research

Missoula, Montana, United States

Site Status

Bryan Health

Lincoln, Nebraska, United States

Site Status

Bryan Women's Care Physicians

Lincoln, Nebraska, United States

Site Status

Midwest Childrens Health Research Institute

Lincoln, Nebraska, United States

Site Status

Meridian Clinical Research, LLC

Norfolk, Nebraska, United States

Site Status

MedPharmics

Albuquerque, New Mexico, United States

Site Status

Winthrop Women's Wellness

Hempstead, New York, United States

Site Status

Sante Comprehensive Women's Healthcare

Johnson City, New York, United States

Site Status

NYU Winthrop Hospital, Research Pharmacy

Mineola, New York, United States

Site Status

NYU Winthrop Hospital

Mineola, New York, United States

Site Status

NYU Winthrop Pediatric Infectious Diseases

Mineola, New York, United States

Site Status

Women's Contemporary Care Associates

Mineola, New York, United States

Site Status

University of Rochester Obstetrics and Gynecology

Rochester, New York, United States

Site Status

University of Rochester Medical Center

Rochester, New York, United States

Site Status

Duke Children's Primary Care - Roxboro Street

Durham, North Carolina, United States

Site Status

Duke Regional Hospital

Durham, North Carolina, United States

Site Status

Duke University Medical Center

Durham, North Carolina, United States

Site Status

Duke University Hospital

Durham, North Carolina, United States

Site Status

Sugarcamp Family Practice

Dayton, Ohio, United States

Site Status

Needmore Medical Center

Dayton, Ohio, United States

Site Status

Kettering Medical Center

Dayton, Ohio, United States

Site Status

HWC Women's Center Research

Englewood, Ohio, United States

Site Status

Lowcountry Womens Specialists

Summerville, South Carolina, United States

Site Status

Summerville Medical Center

Summerville, South Carolina, United States

Site Status

Coastal Pediatric Research

Summerville, South Carolina, United States

Site Status

Center for Women''s Health and Birthcare

Beaumont, Texas, United States

Site Status

CHRISTUS St. Elizabeth Hospital

Beaumont, Texas, United States

Site Status

Gadolin Research, LLC

Beaumont, Texas, United States

Site Status

Pediatric Clinic of Dr. Alvin H. Prause

Beaumont, Texas, United States

Site Status

Texas Health Harris Methodist Hurst-Euless-Bedford Hospital

Bedford, Texas, United States

Site Status

Texas Health Huguley Hospital South

Burleson, Texas, United States

Site Status

8th Avenue Obstetrics and Gynecology

Fort Worth, Texas, United States

Site Status

Baylor Scott & White of Fort Worth

Fort Worth, Texas, United States

Site Status

Texas Health Harris Methodist Hospital FTW

Fort Worth, Texas, United States

Site Status

Ventavia Research Group, LLC

Fort Worth, Texas, United States

Site Status

Texas Health Harris Methodist Hospital Southwest

Fort Worth, Texas, United States

Site Status

University of Texas Medical Branch

Galveston, Texas, United States

Site Status

Chisholm Trail Pediatrics

Georgetown, Texas, United States

Site Status

FMC Science, LLC

Georgetown, Texas, United States

Site Status

Georgetown OBGYN

Georgetown, Texas, United States

Site Status

St. David's Georgetown Hospital

Georgetown, Texas, United States

Site Status

Baylor Scott & White of Grapevine (Hospital)

Grapevine, Texas, United States

Site Status

Dr Van Tran Family Practice

Houston, Texas, United States

Site Status

HG Pediatrics

Houston, Texas, United States

Site Status

Memorial Herman Greater Heights Hospital

Houston, Texas, United States

Site Status

Ventavia Research Group, LLC

Houston, Texas, United States

Site Status

Texas Center for Drug Development, Inc.

Houston, Texas, United States

Site Status

Biopharma Informatic, LLC

Houston, Texas, United States

Site Status

AdventHealth Family Medicine Rural Health Clinic, Inc.

Lampasas, Texas, United States

Site Status

FMC Science

Lampasas, Texas, United States

Site Status

DCOL Center For Clinical Research

Longview, Texas, United States

Site Status

Diagnostic Clinic of Longview

Longview, Texas, United States

Site Status

Longview Regional Medical Center

Longview, Texas, United States

Site Status

Dr. Ruben Aleman and Associates

McAllen, Texas, United States

Site Status

Exygon Clinical Research

Pharr, Texas, United States

Site Status

Texas Health Presbyterian Hospital

Plano, Texas, United States

Site Status

Ventavia Research Group LLC

Plano, Texas, United States

Site Status

Ascension Seton Williamson

Round Rock, Texas, United States

Site Status

Intermountain Medical Center

Murray, Utah, United States

Site Status

JBR Clinical Research

Salt Lake City, Utah, United States

Site Status

Old Farm Obstetrics & Gynecology, LLC

Salt Lake City, Utah, United States

Site Status

St. Marks Hospital

Salt Lake City, Utah, United States

Site Status

Clinical Research Partners, LLC

Richmond, Virginia, United States

Site Status

Johnston Willis Hospital

Richmond, Virginia, United States

Site Status

Cabell Huntington Hospital

Huntington, West Virginia, United States

Site Status

Marshall Health dba University Pediatrics

Huntington, West Virginia, United States

Site Status

Marshall Health Department of Obstetrics and Gynecology

Huntington, West Virginia, United States

Site Status

Translational Genomic Research Institute

Huntington, West Virginia, United States

Site Status

Clinica Mayo De U.M.C.B. S.R.L.

San Miguel de Tucumán, Tucumán Province, Argentina

Site Status

Instituto de Maternidad y Ginecologia, Nuestra Senora de Las Mercedes

San Miguel de Tucumán, Tucumán Province, Argentina

Site Status

Hospital Base San Jose de Osorno

Osorno, Los Lagos Region, Chile

Site Status

Hospital San Borja Arriaran

Santiago, RM, Chile

Site Status

Clinica Universidad de los Andes

Santiago, Santiago Metropolitan, Chile

Site Status

Instituto de Investigaciones Materno Infantil (IDIMI)

Santiago, Santiago Metropolitan, Chile

Site Status

Hospital San Jose

Santiago, Santiago Metropolitan, Chile

Site Status

Grupo Estudios Clinicos Infectologia Respiratoria, Facultad de Medicina Universidad de Chile

Santiago, Santiago Metropolitan, Chile

Site Status

Hospital Clinico Universidad de Chile

Santiago, Santiago Metropolitan, Chile

Site Status

Centro Internacional de Estudios Clinicos - CIEC

Santiago, Santiago Metropolitan, Chile

Site Status

Hospital Padre Hurtado

Santiago, Santiago Metropolitan, Chile

Site Status

Christchurch Clinical Studies Trust Ltd

Christchurch, , New Zealand

Site Status

Christchurch Hospital (Canterbury District Health Board)

Christchurch, , New Zealand

Site Status

Respiratory and Meningeal Pathogens Research Unit (RMPRU)

Soweto, Gauteng, South Africa

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Chile New Zealand South Africa

References

Explore related publications, articles, or registry entries linked to this study.

Simoes EAF, Center KJ, Tita ATN, Swanson KA, Radley D, Houghton J, McGrory SB, Gomme E, Anderson M, Roberts JP, Scott DA, Jansen KU, Gruber WC, Dormitzer PR, Gurtman AC. Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy. N Engl J Med. 2022 Apr 28;386(17):1615-1626. doi: 10.1056/NEJMoa2106062.

Reference Type DERIVED
PMID: 35476650 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://pmiform.com/clinical-trial-info-request?StudyID=C3671003

To obtain contact information for a study center near you, click here.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C3671003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.